Redefine Surgery Closes Oversubscribed Pre-Seed Round and Announces Catalyst OrthoScience Partnership
Backed predominantly by surgeon investors, Redefine has raised $10 million to advance its surgical intelligence platform toward commercialization. Catalyst OrthoScience joins as its Founding Partner in developing surgical intelligence for shoulder arthroplasty. EDISON, N.J. — Redefine Surgery, a medical technology company building physical AI for surgery, today announced the closing of an…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
